J. Hare - Comparison of Allogen vs Autolog Mesenchymal Stem Cells in Pts. with Ischemic CMP
J. Hare - Randomized Comparison of Allogeneic vs Autologous Mesenchymal Stem Cells in Patients with Ischemic Cardiomyopathy POSEIDON - This trial was designed to test the safety and efficacy of allogeneic vs. autologous mesenchymal stem cells in patients with ischemic cardiomyopathy. Annual Session of the American Heart Association November 5, 2012, Los AngelesFrom:CardioletterViews:0 0ratingsTime:08:37More inScience Technology
Read the rest here:
J. Hare - Comparison of Allogen vs Autolog Mesenchymal Stem Cells in Pts. with Ischemic CMP - Video